On November 4, 2021, BDgene was signed with Minhang Economic and Technological Development Zone, from Minhang to the world, opening the next journey of gene therapy innovation drugs.
BDgene has developed under the leadership of Cai Yaga, since 2018. At present, the company has completed 2 rounds of financing, gaining three Iit ethical approval, launched the three pilot lines, and established a deep cooperation with the top clinical PI of the industry, and reached a project research and development cooperation with famous international pharmaceutical companies.
The Minhang District has just released the "Minhang District on promoting the high-quality development of the biomedical industry", support R & D innovation, promoting industrial development, improve platform support, and a number of measures to promote the high - quality development of biomedical industry. BDGENE settled in Minhang Development Zone, followed by the development of the biomedical industry in Minhang District, seizing the opportunities of development, and striving to become a domestic leading gene therapy innovation drug research and development enterprise.
Shanghai BDgene Technology Co., Ltd. (BDgene) was established in 2018. The founder team has a top scientist in gene therapy, and has an international expert with an international pharmaceutical enterprise and an anabilistic expert with clinical drug evaluation experience. . The consultant team includes the authoritative experts of the gene therapy industry, the clinician of top three hospitals, the senior manager of listed pharmaceutical companies. Focusing on the law of new drug development, the company has formed a new drug development team containing CMC, quality, QA, R & D, registration department. The team has very strong research and development and industrialization, and familiar with China's local culture has an international field of vision. The company has international leading innovative technology platform BDlenti and BDmRNA, which has received wide concerns from domestic and foreign research institutions and pharmaceutical companies to help the company grow into top bio pharmaceutical companies.
Minhang Economic and Technological Development Zone is located in the south of Minhang District. It is one of the first batch of 14 national development zones approved by the State Council, within the construction of the Southern Science Center, Shanghai. The '闵 虹 智 造 源' in the Subway Line 5 is located in Minhang Development Zone Station, close to Shanghai Jiaotong University, East China Normal University, the park leading advanced equipment manufacturing, biomedicine, artificial intelligence and other industries, supporting apartment, business and other facilities .